Urology
Volume 59, Issue 6 , Pages 877-883 , June 2002

Prevalence of and racial/ethnic variation in lower urinary tract symptoms and noncancer prostate surgery in U.S. men

  • Elizabeth A Platz

      Affiliations

    • Corresponding Author InformationReprint requests: Elizabeth A. Platz, Sc.D., M.P.H., Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Room E6143, Baltimore, MD 21205, USA
    • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
    • ,
  • Ellen Smit

      Affiliations

    • Department of Social and Preventive Medicine, State University of New York at Buffalo School of Medicine, Buffalo, New York, USA
    • ,
  • Gary C Curhan

      Affiliations

    • Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
    • ,
  • Leroy M Nyberg Jr

      Affiliations

    • Division of Kidney, Urologic, and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA
    • ,
  • Edward Giovannucci

      Affiliations

    • Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, Boston, Massachusetts, USA
    • Channing Laboratory, Department of Medicine, Harvard Medical School and Brigham and Women’s Hospital, Boston, Massachusetts, USA

Received 15 October 2001 ,Revised 12 December 2001 ,Accepted 12 December 2001.

References 

  1. National Center for Health Statistics . Plan and Operation of the Third National Health and Nutrition Examination Surgery, 1988-94. Vital Health Statistics DHHS Pub. No. (PHS) 92-1509 (Series 1, No 32). 1994; Hyattsville, Maryland, U.S. Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Health Statistics
  2. Shah BV, Barnwell BG, Hunt PN, et al.  SUDAAN User’s Manual. Research Triangle Park, North Carolina: Research Triangle Institute; 1991; release 5.50
  3. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed.. New York: John Wiley & Sons; 1981;
  4. Trueman P, Hood SC, Nayak USL, et al.  Prevalence of lower urinary tract symptoms and self-reported diagnosed “benign prostatic hyperplasia” and their effect on quality of life in a community-based survey of men in the UK. Br J Urol. 1999;83:410–415
  5. Sagnier PP, Girman CJ, Garraway M, et al.  International comparison of the community prevalence of symptoms of prostatism in four countries. Eur Urol. 1996;29:15–20
  6. Derbes VDP, Leche SM, Hooker CW. The incidence of benign prostatic hypertrophy among the whites and Negroes in New Orleans. J Urol. 1937;38:383–388
  7. D’Aunoy R, Schenken JR, Burns EL. The relative incidence of hyperplasia of the prostate in the white and colored races in Louisiana. South Med J. 1939;32:47–52
  8. Conger KB. Racial incidence of prostatism in Hawaii (a report of 172 consecutive cases). J Urol. 1947;58:444–447
  9. Chang HL, Char GY. Benign hypertrophy of the prostate. Chinese Med J. 1936;50:1707–1722
  10. Morrison AS. Risk factors for surgery for prostatic hypertrophy. Am J Epidemiol. 1992;135:974–980
  11. Morrison AS. Prostatic hypertrophy in greater Boston. J Chron Dis. 1978;31:357–362
  12. Lytton B, Emery JM, Harvard BM. The incidence of benign prostatic obstruction. J Urol. 1968;99:639–645
  13. Sidney S, Quesenberry C, Sadler MC, et al.  Risk factors for surgically treated benign prostatic hyperplasia in a prepaid health care plan. Urology. 1991;38(suppl):13–19
  14. Xia Z, Roberts RO, Schottenfeld D, et al.  Trends in prostatectomy for benign prostatic hyperplasia among black and white men in the United States (1980 to 1994). Urology. 1999;53:1154–1159
  15. Platz E, Kawachi I, Rimm E, et al.  Race, ethnicity and benign prostatic hyperplasia in the Health Professionals Follow-up Study. J Urol. 2000;163:490–495
  16. Armenian HK, Lilienfeld AM, Diamond EL, et al.  Epidemiologic characteristics of patients with prostatic neoplasms. Am J Epidemiol. 1975;102:47–54
  17. Araki H, Watanabe H, Mishina T, et al.  High-risk group for benign prostatic hypertrophy. Prostate. 1983;4:253–264
  18. Glynn RJ, Campion EW, Bouchard GR, et al.  The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidemiol. 1985;121:78–90
  19. Lee E, Park MS, Shin C, et al.  A high-risk group for prostatism (a population-based epidemiological study in Korea). Br J Urol. 1997;79:736–741
  20. Signorello LB, Tzonou A, Lagiou P, et al.  The epidemiology of benign prostatic hyperplasia (a study in Greece). Br J Urol. 1999;84:286–291
  21. Moon TD, Brannan W, Stone NN, et al.  Effect of age, educational status, ethnicity and geographic location on prostate symptom scores. J Urol. 1994;152:1498–1500
  22. Haidinger G, Madersbacher S, Waldhoer T, et al.  The prevalence of lower urinary tract symptoms in Austrian males and associations with sociodemographic variables. Eur J Epidemiol. 1999;15:717–722
  23. Chyou PH, Nomura AMY, Stemmermann GN, et al.  A prospective study of alcohol, diet, and other lifestyle factors in relation to obstructive uropathy. Prostate. 1993;22:253–264
  24. Barry MJ, Fowler FJ, O’Leary MP, et al.  The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 1992;148:1549–1557
  25. Patient Outcomes Research Team for Prostatic Diseases Wasson JH, Bubloz TA, Lu-Yao GL, et al.  Transurethral resection of the prostate among Medicare beneficiaries (1997). J Urol. 2000;164:1212–1215

☆ This work was supported by the National Institute for Diabetes and Digestive and Kidney Diseases.

PII: S0090-4295(01)01673-9

Urology
Volume 59, Issue 6 , Pages 877-883 , June 2002

Article Tools